Evidence map›Paper›PMID 31836601›Full record

ArticleCancer research2019

RadioGx: A New Preclinical Tool to Model Intrinsic Radiosensitivity.

Daniel E Spratt, Corey Speers

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Daniel E SprattRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Corey SpeersRogel Cancer Center, University of Michigan, Ann Arbor, Michigan. cspeers@med.umich.edu.ORCID 0000-0002-2362-2860

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy is perhaps the most ubiquitous single treatment modality for patients with cancer. Despite its routine use, biomarkers of treatment response are critically lacking, and the biology underlying the heterogeneity in clinical response to radiation treatment remain largely unknown. In this issue of

Indexed as

NeoplasmsRadiation ToleranceHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.